Searching the RRID Resource Information Network
Are you sure you want to leave this community? Leaving the community will revoke any permissions you have been granted in this community.
SciCrunch Registry is a curated repository of scientific resources, with a focus on biomedical resources, including tools, databases, and core facilities - visit SciCrunch to register your resource.
| Resource Name | Proper Citation | Abbreviations | Resource Type |
Description |
Keywords | Resource Relationships | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
CRISPResso Resource Report Resource Website 10+ mentions |
CRISPResso (RRID:SCR_021538) | data analysis software, data processing software, sequence analysis software, software application, software resource, software toolkit | Software suite of tools to qualitatively and quantitatively evaluate outcomes of genome editing experiments in which target loci are subject to deep sequencing and provides integrated, user friendly interface. Used for analysis of CRISPR-Cas9 genome editing outcomes from sequencing data. CRISPResso2 provides accurate and rapid genome editing sequence analysis.Used for analysis of deep sequencing data for rapid and intuitive interpretation of genome editing experiments. | Quantification, visualization, CRISPR-Cas9 outcomes, coding sequences evaluation, noncoding elements evaluation, selected off target sites evaluation, genome editing evaluation. | NHGRI R00 HG008399; NHGRI R01 HG005085; NHGRI RM1 HG009490; NHLBI P01 HL32262; NHLBI R01 HL119099; NIBIB R01 EB022376; NIDDK P30 DK049216; NIDDK R03 DK109232; NIGMS R35 GM118062; NIGMS R35 GM118158 |
PMID:27404874 PMID:30809026 |
Free, Available for download, Freely available | https://github.com/pinellolab/CRISPResso2, https://github.com/pinellolab/CRISPResso | SCR_021538 | CRISPResso2 | 2026-09-19 12:54:54 | 27 | |||||||
|
Vanderbilt Diabetes Research and Training Center Vanderbilt Diet Body Composition and Metabolism Core Facility Resource Report Resource Website |
Vanderbilt Diabetes Research and Training Center Vanderbilt Diet Body Composition and Metabolism Core Facility (RRID:SCR_010191) | access service resource, core facility, service resource | THIS RESOURCE IS NO LONGER IN SERVICE. Documented on October 30,2023. Core facility that provides training and expertise in nutrition/diet methodology to obtain valid and reliable assessment and analyses of dietary intakes, nutritional status, body composition and metabolism. | diabetes, nutrition methodology, body composition, metabolism |
is listed by: Eagle I is listed by: NIDDK Information Network (dkNET) has parent organization: Vanderbilt University; Tennessee; USA has parent organization: Vanderbilt Diabetes Research and Training Center is organization facet of: Vanderbilt Diabetes Research and Training Center |
Diabetes | NIDDK DK020593 | THIS RESOURCE IS NO LONGER IN SERVICE | nlx_156670 | SCR_010191 | Vanderbilt Diabetes Research and Training Center Vanderbilt Diet Body Composition and Metabolism Core | 2026-09-19 12:58:55 | 0 | ||||||
|
Peginterferon and Ribavirin for Pediatric Patients with Chronic Hepatitis C Resource Report Resource Website |
Peginterferon and Ribavirin for Pediatric Patients with Chronic Hepatitis C (RRID:SCR_006787) | PEDS-C | clinical trial, resource | Multi-center, randomized controlled trial that studied peginterferon therapy, with or without ribavirin, in children with chronic hepatitis C. Approximately 120 children were randomly assigned to receive peginterferon alfa-2a alone or peginterferon with ribavirin for 48 weeks. Samples of blood, genomic DNA, and liver tissue are stored in the NIDDKrepositories. A long-term follow up study of the clinical trial participants is underway. | child, young human, peginterferon alfa-2a, ribavirin, drug, male, female, adolescent, pediatric |
is listed by: One Mind Biospecimen Bank Listing is listed by: NIDDK Research Resources is listed by: NIDDK Information Network (dkNET) is related to: NIDDK Central Repository has parent organization: ClinicalTrials.gov |
Chronic hepatitis C viral infection, Hepatitis C virus | NIDDK | PMID:18042575 | nlx_152846 | http://www.pedsc.org | SCR_006787 | Pegylated Interferon +/- Ribavirin for Children With Hepatitis C, Peginterferon and Ribavirin for Pediatric Patients with Chronic Hepatitis C (Peds-C) | 2026-09-19 12:58:39 | 0 | ||||
|
Evaluating Predictors and Interventions in Sphincter of Oddi Dysfunction Resource Report Resource Website |
Evaluating Predictors and Interventions in Sphincter of Oddi Dysfunction (RRID:SCR_006897) | EPISOD | clinical trial, resource | A prospective, double-blind, randomized, sham-controlled, multi-center clinical trial that enrolls subjects who have received a prior cholecystectomy and are diagnosed with the clinical syndrome of Sphincter of Oddi Dysfunction III (SOD III) as defined by the Rome III criteria. The goal of the study is to asses the value of endoscopic sphincterotomy as a treatment for adult subjects categorized as SOD III suffering from pain after cholecystectomy and to define the role of manometry in treating these patients. | clinical, treatment, intervention, sphincterotomy, pancreatic, pancreas, pancreatitis, biliary, adult human, male, female, manometry |
is listed by: ClinicalTrials.gov is listed by: NIDDK Information Network (dkNET) is listed by: NIDDK Research Resources |
Cholecystectomy, Sphincter of Oddi Dysfunction | NIDDK | nlx_152824 | http://www.episod.org/ | SCR_006897 | Evaluating Predictors & Interventions in Sphincter of Oddi Dysfunction, Evaluating Predictors & Interventions in Sphincter of Oddi Dysfunction (EPISOD) | 2026-09-19 12:58:39 | 0 | |||||
|
Complementary and Alternative Medicine for Urological Symptoms Resource Report Resource Website |
Complementary and Alternative Medicine for Urological Symptoms (RRID:SCR_007131) | CAMUS | clinical trial, resource | Randomized, multicenter, double blind, placebo controlled clinical trial of phytotherapy for benign prostate symptoms among men. The CAMUS trial will test Saw palmetto in about 369 men. Men who decide to be part of the CAMUS trial will be given one out of two possible treatments at random. One out of every two men would get an inactive placebo treatment. One out of every two men would get Saw palmetto pills. This kind of scientific study is the best way to find out if the plant extracts really work to prevent men with benign prostatic hyperplasia (BPH) from getting worse. During the study, men will not know which of the two treatments they are assigned to. They will be followed very closely by a study team every 12 weeks to see how they are doing. Men in the CAMUS trial will be studied over 72 weeks. Ten clinical centers will participate in the trial. They are located at: Columbia University, NY, NY; New York University, NY, NY; University of Texas Southwestern Medical Center, Dallas, Texas; University of Colorado, Denver, CO; Washington University, St. Louis, MO; Yale University, New Haven, CT; Queens University, Hamilton, Ontario, Canada; Northwestern University, Chicago, IL; University of Maryland, Baltimore, MD; University of California at San Francisco, San Francisco, CA. | phytotherapy, prostate, benign, treatment, male, adult human, saw palmetto, placebo, herbal therapy, middle adult human, late adult human, urology |
is listed by: ClinicalTrials.gov is related to: NIDDK Information Network (dkNET) has parent organization: University of Alabama at Birmingham; Alabama; USA |
Benign prostatic hyperplasia | NCCAM ; NIDDK ; Office of Dietary Supplements ; NIDDK U01DK63795; NIDDK U01DK63797; NIDDK U01DK63825; NIDDK U01DK63835; NIDDK U01DK63866; NIDDK U01DK63833; NIDDK U01DK63862; NIDDK U01DK63840; NIDDK U01DK63883; NIDDK U01DK63831; NIDDK U01DK63778; NIDDK U01DK63788 |
PMID:21954478 PMID:21741692 PMID:21497839 |
nlx_152791 | http://www.camus.uab.edu/camus/html/index.htm |
SCR_007131 | Complementary and Alternative Medicine for Urological Symptoms Clinical Trial, Complementary and Alternative Medicine for Urological Symptoms (CAMUS) Clinical Trial, Complementary and Alternative Medicine for Urological Symptoms (CAMUS) | 2026-09-19 12:58:39 | 0 | ||||
|
Focal Segmental Glomerulosclerosis in Children and Young Adults Interventional Study Resource Report Resource Website |
Focal Segmental Glomerulosclerosis in Children and Young Adults Interventional Study (RRID:SCR_007130) | FSGS in Children and Young Adults Interventional Study | clinical trial, resource | Network of collaborative research centers that tested the effects of treatment with cyclosporine to treatment with mycophenalate mofetil combined with oral pulse dexamethasone in children and young adults with focal segemental glomerulosclerosis. Efficacy was assessed in terms of induction of remission of proteinuria after 52 weeks of treatment and sustained remission after 26 weeks off treatment. The clinical sites were State University of New York, Stony Brook; Montefiore Medical Center; Seattle Children''''s Medical Center; Medical City Dallas Hospital; and the University of North Carolina. The Cleveland Clinic is the data-coordinating center, and NephCure will fund ancillary studies. | child, early adult, young human, proteinuria, kidney disease, intervention, prednisone, cyclosporine, mycophenalate mofetil, dexamethasone, cyclosporine-a, male, female |
is listed by: ClinicalTrials.gov is affiliated with: NIDDK - National Institute of Diabetes and Digestive and Kidney Diseases is related to: NIDDK Information Network (dkNET) has parent organization: NIDDK - National Institute of Diabetes and Digestive and Kidney Diseases |
Focal Segmental Glomerulosclerosis, Focal Segmental Glomerulosclerosis Nephrotic Syndrome | NIDDK | nlx_152826 | http://www.fsgstrial.org | SCR_007130 | Focal Segmental Glomerulosclerosis Clinical Trial, Focal Segmental Glomerulosclerosis Clinical Trial (FSGS-CT), Focal Segmental Glomerulosclerosis (FSGS) Clinical Trial, Focal Segmental Glomerulosclerosis (FSGS) in Children and Young Adults Interventional Study | 2026-09-19 12:58:39 | 0 | |||||
|
Minimally Invasive Surgical Therapies Treatment Consortium for Benign Prostatic Hyperplasia Resource Report Resource Website |
Minimally Invasive Surgical Therapies Treatment Consortium for Benign Prostatic Hyperplasia (RRID:SCR_007126) | MIST for BPH | clinical trial, resource | Randomized clinical trial to determine the efficacy and safety of three treatments for benign prostatic hyperplasia (BPH): transurethral needle ablation (TUNA), transurethral microwave therapy (TUMT), and medical therapy with alfuzosin and finasteride. The study has been terminated. (Inability to recruit required sample size.) | transurethral microwave thermotherapy, transurethral needle ablation, therapy, drug, finasteride, alfuzosin, treatment, clinical, intervention, male, middle adult human, late adult human, prostate |
is listed by: ClinicalTrials.gov is related to: NIDDK Information Network (dkNET) has parent organization: NIDDK - National Institute of Diabetes and Digestive and Kidney Diseases |
Benign Prostatic Hyperplasia | NIDDK | nlx_152844 | SCR_007126 | Minimally Invasive Surgical Therapies (MIST) Treatment Consortium for Benign Prostatic Hyperplasia (BPH), Minimally Invasive Surgical Therapy Consortium for Benign Prostatic Hyperplasia | 2026-09-19 12:58:39 | 0 | ||||||
|
University of Pennsylvania School of Medicine Penn Diabetes Research Center Pancreatic Islet Cell Biology Core Facility Resource Report Resource Website |
University of Pennsylvania School of Medicine Penn Diabetes Research Center Pancreatic Islet Cell Biology Core Facility (RRID:SCR_008265) | access service resource, core facility, resource, service resource | Core that gives support including experimental design, islet isolation, and performance of and training in an expansive range of assays for physiological and morphometric assessment of pancreatic islet function and growth. It contributes to the basic and translational research activities of the Institute of Diabetes, Obesity and Metabolism (IDOM) at the Perelman School of Medicine of the University of Pennsylvania. Its services include perform individual islet and single cell fluorescence imaging, respirometry with islet batches using a Seahorse Extracellular Flux Analyzer, perifusion coupled with respirometry, and closed respirometry experiments for our investigators. | calcium imaging, mitochondrial function, morphometry, islet isolation |
is listed by: Eagle I is listed by: NIDDK Information Network (dkNET) has parent organization: University of Pennsylvania; Philadelphia; USA has parent organization: Penn Diabetes Research Center is organization facet of: Penn Diabetes Research Center |
Diabetes | NIDDK P30DK19525 | Available to the DRC community, Fee for service | nlx_156487 | SCR_008265 | Penn Diabetes Research Center Pancreatic Islet Cell Biology Core | 2026-09-19 12:58:40 | 0 | ||||||
|
University of North Carolina Center for Gastrointestinal Biology and Disease Microbiome Core Resource Report Resource Website 1+ mentions |
University of North Carolina Center for Gastrointestinal Biology and Disease Microbiome Core (RRID:SCR_012644) | UNC School of Medicine Microbiome Core Facility | access service resource, core facility, service resource | Core facility that provides the research community with the facilities and the expertise to characterize complex microbial communities from different environments.Services offered by the Core include metagenomics methods to determine the composition and function of microbial communities using amplicon, Whole Genome Shotgun (WGS) and RNA sequencing, and traditional and high-throughput quantitative (q)PCR. | metagenomics, microbial community, rna sequencing |
is listed by: NIDDK Information Network (dkNET) is listed by: ABRF CoreMarketplace has parent organization: University of North Carolina at Chapel Hill School of Medicine; North Carolina; USA has parent organization: University of North Carolina Center for Gastrointestinal Biology and Disease is organization facet of: University of North Carolina Center for Gastrointestinal Biology and Disease |
digestive disease | NIDDK P30 DK034987 | Available to the research community | ABRF_5660, SciEx_604 | https://https://coremarketplace.org/?FacilityID=5660&citation=1 | SCR_012644 | , University of North Carolina at Chapel Hill School of Medicine Microbiome Core Facility, UNC Microbiome Core | 2026-09-19 12:59:12 | 1 | ||||
|
Renin Angiotensin System Study Resource Report Resource Website 1+ mentions |
Renin Angiotensin System Study (RRID:SCR_013385) | RASS/B-RASS, RASS | clinical trial, resource | Randomized, multicenter, double-blind study to determine if renin angiotensin medications, either losartan (angiotensin II blocker) or enalapril (converting enzyme inhibitor), can prevent or delay the onset of diabetic kidney disease in patients with type 1 diabetic patients who do not have hypertension, diabetic nephropathy, or predictive levels of microalbuminuria. Two hundred eight five patients ages 16-61 with 2-20 yrs of Type 1 Diabetes Mellitus and no renal functional abnormalities were randomized into a parallel, double-blind, placebo-controlled study involving 3 groups (95 patients/group). Each group received an angiotensin-converting enzyme inhibitor (ACEI) (enalapril), or an angiotensin II receptor blocker (Losartan), or placebo. All patients had their usual Diabetes Mellitus (DM) management. Baseline studies included measures of glomerular filtration rate (GFR), urinary albumin excretion rate (UAE), blood pressure (BP), and a percutaneous renal biopsy. Patients were followed by quarterly measures of BP, HbA1C, UAE, and drug compliance. There were annual measures of GFR and a repeat renal biopsy after 5 yrs in the study. The main endpoint is kidney structural changes over time, especially mesangial fractional volume (v(Mes/glom)). Secondary endpoints will be other DN structural measures and measures of kidney function (UAE, GFR). These studies will determine whether rennin angiotensin system blockage in the early stages of DN can prevent the early kidney structural changes in this important disorder. Ancillary studies will evaluate the effects of treatment group on the development and progression of diabetic retinopathy and will develop predictors of study participants'''' compliance. Baseline, 2.5 and 5 year retinal fundus photographs in the RASS patients were obtained. | enalapril, drug, losartan, angiotensin, medication, kidney, intervention, clinical, adolescent, adult human, renal biopsy, renin-angiotensin system, diabetic nephropathy, kidney, placebo, glomerular filtration rate, urinary albumin excretion rate, blood pressure |
is related to: NIDDK Information Network (dkNET) has parent organization: ClinicalTrials.gov has parent organization: University of Minnesota Twin Cities; Minnesota; USA |
Type 1 diabetes, Diabetic kidney disease, Retinopathy, Nephropathy, Diabetes | NIDDK | PMID:19571282 | nlx_152849 | SCR_013385 | Renin Angiotensin System Blockage-DN (RASS), Renin Angiotensin System Study (RASS/B-RASS) | 2026-09-19 12:59:14 | 1 | |||||
|
Einstein-Mount Sinai Diabetes Research Center Human Islet and Adenovirus Core Facility Resource Report Resource Website |
Einstein-Mount Sinai Diabetes Research Center Human Islet and Adenovirus Core Facility (RRID:SCR_015066) | access service resource, core facility, service resource | Core which provides methodologies, technology and infrastructure to support investigators in the use of human islets for research studies for the Einstein-Mount Sinai Diabetes Research Center. It isolates and prepares human and rodent islets/beta cells and cell lines for investigator-initiated research and generates specific viral vectors (adenovirus and lentivirus) for gene delivery of cDNAs and shRNAs of interest to beta cells and other islet cell types. | islets, human islets, beta cells, adenovirus |
is listed by: NIDDK Information Network (dkNET) is listed by: ABRF CoreMarketplace has parent organization: Einstein-Mount Sinai Diabetes Research Center is organization facet of: Einstein-Mount Sinai Diabetes Research Center |
New York Obesity Research Center ; Center for the Study of Diabetic Complications ; Montefiore Clinical Diabetes Center ; NIDDK P30DK020541 |
Open | ABRF_2863 | https://coremarketplace.org/?FacilityID=2863&citation=1 | http://www.einstein.yu.edu/centers/diabetes-research/human-Islet-and-adenovirus-core/ | SCR_015066 | Einstein-Mount Sinai Diabetes Research Center Human Islet and Adenovirus Core | 2026-09-19 12:59:16 | 0 | |||||
|
Einstein-Mount Sinai Diabetes Research Center Biomarker Analytic Research Core Facility Resource Report Resource Website 10+ mentions |
Einstein-Mount Sinai Diabetes Research Center Biomarker Analytic Research Core Facility (RRID:SCR_015067) | BARC | access service resource, core facility, service resource | Core provides information and tools for Einstein and Montefiore investigators from initial study planning stage through analysis and data output. Facility services include: mass spectrometry analysis, including stable isotopes, as well as research-grade determination of lipids, and metabolic markers for human subjects and animal model projects; High-throughput robotics for semi-automated high-quality sample preparation and analysis by immunoassay and liquid chromatography–mass spectrometry (LC/MS); Support for novel developmental projects featuring applications of LC/MS and two-site bead-based assays; Research quality analysis of metabolites for human and animal samples using Olympus AU400 autoanalyzer; Advanced training in analytical chemistry. | analytical research tools, biomarker core, mass spectrometry analysis, stable isotopes, lipids, metabolic markers, analytical chemistry, |
is listed by: NIDDK Information Network (dkNET) is listed by: ABRF CoreMarketplace has parent organization: Einstein-Mount Sinai Diabetes Research Center is organization facet of: Einstein-Mount Sinai Diabetes Research Center |
Diabetes | New York Obesity Research Center ; Center for the Study of Diabetic Complications ; Montefiore Clinical Diabetes Center ; NIDDK P30DK020541 |
Restricted | ABRF_2862 | https://coremarketplace.org/?FacilityID=2862&citation=1 | http://www.einstein.yu.edu/centers/diabetes-research/wrap.aspx?id=45634 | SCR_015067 | Einstein-Mount Sinai Diabetes Research Center Biomarker and Analytical Research Core, Einstein-Mount Sinai Diabetes Research Center Biomarker Analytic Research Core | 2026-09-19 12:59:16 | 29 | |||
|
University of California San Francisco Diabetes Research Center Mouse Genetics Core Facility Resource Report Resource Website |
University of California San Francisco Diabetes Research Center Mouse Genetics Core Facility (RRID:SCR_015109) | access service resource, core facility, service resource | THIS RESOURCE IS NO LONGER IN SERVICE. Documented on November 5,2024. Core that provides a shared resource for the establishment of mutant mouse models for DRC research. It coordinates DRC members with contacts to a number of UCSF-wide facilities for knock-out/knock-in and transgenic mouse generation. | mouse genetics, transgenic mice, mutant models, type 1 and type 2 diabetes research |
is listed by: NIDDK Information Network (dkNET) has parent organization: University of California at San Francisco; California; USA has parent organization: University of California San Francisco Diabetes Research Center is organization facet of: University of California San Francisco Diabetes Research Center |
Type 1 diabetes, Type 2 diabetes, Diabetes | NIDDK P30DK063720 | THIS RESOURCE IS NO LONGER IN SERVICE | SCR_015109 | 2026-09-19 12:59:17 | 0 | ||||||||
|
University of Alabama at Birmingham Diabetes Research Center Administrative Core Facility Resource Report Resource Website |
University of Alabama at Birmingham Diabetes Research Center Administrative Core Facility (RRID:SCR_015108) | access service resource, core facility, service resource | Core responsible for the scientific, education/enrichment, and fiscal operations of the DRC. Their goal is to assure the growing vitality of an intellectual community and a highly productive research program in diabetes by effective deployment of DRC resources for the benefit of our investigators, patients, and trainees. | fiscal operations of DRC, Pilot and Feasibility Grant Program, Enrichment Program, |
is listed by: NIDDK Information Network (dkNET) is listed by: ABRF CoreMarketplace has parent organization: University of Alabama at Birmingham; Alabama; USA has parent organization: University of Alabama at Birmingham Diabetes Research Center is organization facet of: University of Alabama at Birmingham Diabetes Research Center |
Diabetes | NIDDK DK079626 | Restricted | ABRF_2970 | https://coremarketplace.org/?FacilityID=2970&citation=1 | SCR_015108 | 2026-09-19 12:59:17 | 0 | ||||||
|
University of Alabama at Birmingham Diabetes Research Center Bioanalytical REDOX Biology Core Facility Resource Report Resource Website |
University of Alabama at Birmingham Diabetes Research Center Bioanalytical REDOX Biology Core Facility (RRID:SCR_015113) | access service resource, core facility, service resource | Core which promotes redox biology in diabetes-related research. It promotes research in areas common to the metabolic and vascular aspects of diabetes and cardiovascular disease. The core provides services in mitochondrial damage, function, proteomics, and oxidative stress assessment support for investigators carrying out diabetes mellitus (DM) and cardiometabolic disease (CMD) research at UAB. | ABRF, metabolic molecular processes, cardiometabolic disease, vascular disease |
is listed by: NIDDK Information Network (dkNET) is listed by: ABRF CoreMarketplace has parent organization: University of Alabama at Birmingham; Alabama; USA has parent organization: University of Alabama at Birmingham Diabetes Research Center is organization facet of: University of Alabama at Birmingham Diabetes Research Center |
Diabetes | NIDDK DK079626 | Restricted | ABRF_2973 | https://coremarketplace.org/?FacilityID=2973&citation=1 | SCR_015113 | , BARB Core, Bio-Analytical Redox Biology (BARB) Core | 2026-09-19 12:59:17 | 0 | |||||
|
Columbia Diabetes Research Center Translational Biomarker Analytical Core Facility Resource Report Resource Website |
Columbia Diabetes Research Center Translational Biomarker Analytical Core Facility (RRID:SCR_015077) | TBAC | access service resource, core facility, service resource | Core makes available to Diabetes Research Center investigators variety of high quality radio-immunoassay, ELISA, and other analytical methods, and facilitates access of DRC investigators to measurement of small molecules by targeted and untargeted metabolomics/lipidomics with the Irving Institute Biomarkers Core. TBAC also provides consultations and services for in vivo methods to measure insulin secretion and sensitivity. | radioimmunoassay, ELISA, translational biomarker, small molecules, measure insulin secretion and sensitivity, |
is listed by: NIDDK Information Network (dkNET) is listed by: ABRF CoreMarketplace has parent organization: Columbia University; New York; USA is organization facet of: Columbia Diabetes Research Center |
Diabetes | NIDDK P30DK063608 | Open | ABRF_2859 | https://coremarketplace.org/?FacilityID=2859&citation=1 | https://www.derc.cumc.columbia.edu/core-facilities-and-services/translational-biomarker-analytical-core | SCR_015077 | , Columbia Diabetes Research Center Translational Biomarker Analytical Core, Translational Biomarker Analytical Core (TBAC) | 2026-09-19 12:59:17 | 0 | |||
|
University of Alabama at Birmingham Diabetes Research Center Human Physiology Core Facility Resource Report Resource Website |
University of Alabama at Birmingham Diabetes Research Center Human Physiology Core Facility (RRID:SCR_015111) | access service resource, core facility, service resource | Core which incorporates and combines expertise and technology for assessment of hormones and other analytes in both humans and animal models; body composition and fat distribution; insulin sensitivity and substrate metabolism; energy expenditure; and cardiovascular function. | ABRF, serum analysis, human cardiovascular function, glucose tolerance testing, human body composition |
is listed by: NIDDK Information Network (dkNET) is listed by: ABRF CoreMarketplace has parent organization: University of Alabama at Birmingham; Alabama; USA has parent organization: University of Alabama at Birmingham Diabetes Research Center is organization facet of: University of Alabama at Birmingham Diabetes Research Center |
Diabetes | NIDDK DK079626 | Open | ABRF_2972 | https://coremarketplace.org/?FacilityID=2972&citation=1 | SCR_015111 | Human Physiology Core | 2026-09-19 12:59:17 | 0 | |||||
|
Johns Hopkins University - University of Maryland Diabetes Research Center Molecular and Translational Genomics Core Resource Report Resource Website |
Johns Hopkins University - University of Maryland Diabetes Research Center Molecular and Translational Genomics Core (RRID:SCR_015116) | access service resource, core facility, service resource | THIS RESOURCE IS NO LONGER IN SERVICE. Documented on November 6,2024. Core that provides services in genotyping, sequencing, biobanks, and genetic epidemiology. It also offers access to the Amish exome variant database, basic molecular services, and viral vector construction and development. | genotyping service, sequencing service, biobank access, basic molecular service, vector construction, vector development |
is listed by: NIDDK Information Network (dkNET) has parent organization: Johns Hopkins University - University of Maryland Diabetes Research Center is organization facet of: Johns Hopkins University - University of Maryland Diabetes Research Center |
Diabetes | NIDDK P30DK079637 | THIS RESOURCE IS NO LONGER IN SERVICE | SCR_015116 | 2026-09-19 12:59:17 | 0 | ||||||||
|
Michigan Diabetes Research Center OMICS Core Resource Report Resource Website |
Michigan Diabetes Research Center OMICS Core (RRID:SCR_015117) | access service resource, core facility, service resource | THIS RESOURCE IS NO LONGER IN SERVICE. Documented on November 6,2024. Core that supports the use of the OMICS technologies by MDRC members (specifically on projects relevant to diabetes and related endocrine and metabolic disorders, including their complications) by supporting pilot studies that utilize these technologies. | omics, pilot studies, funding | is listed by: NIDDK Information Network (dkNET) | Diabetes | NIDDK P30DK020572 | THIS RESOURCE IS NO LONGER IN SERVICE | SCR_015117 | 2026-09-19 12:59:17 | 0 | ||||||||
|
Einstein-Mount Sinai Diabetes Research Center Stable Isotope and Metabolomics Core Facility Resource Report Resource Website |
Einstein-Mount Sinai Diabetes Research Center Stable Isotope and Metabolomics Core Facility (RRID:SCR_015071) | access service resource, core facility, service resource | Core which uses stable isotope flux and metabolite profiling to help formulate and test hypotheses about the metabolic consequences of various changes in gene expression and protein function, in order to guide further integrative systems biology analyses of the underlying mechanisms in diabetes, insulin resistance, obesity, and diabetic complications. | stable isotope, insulin resistance, bile acids |
is listed by: NIDDK Information Network (dkNET) has parent organization: Einstein-Mount Sinai Diabetes Research Center is organization facet of: Einstein-Mount Sinai Diabetes Research Center |
Diabetes | Center for the Study of Diabetic Complications ; Montefiore Clinical Diabetes Center ; New York Obesity Research Center ; NIDDK P30DK020541 |
Open | SCR_015071 | Einstein-Mount Sinai Diabetes Research Center Stable Isotope and Metabolomics Core | 2026-09-19 12:59:16 | 0 |
Can't find your Tool?
We recommend that you click next to the search bar to check some helpful tips on searches and refine your search firstly. Alternatively, please register your tool with the SciCrunch Registry by adding a little information to a web form, logging in will enable users to create a provisional RRID, but it not required to submit.
Welcome to the dkNET Resources search. From here you can search through a compilation of resources used by dkNET and see how data is organized within our community.
You are currently on the Community Resources tab looking through categories and sources that dkNET has compiled. You can navigate through those categories from here or change to a different tab to execute your search through. Each tab gives a different perspective on data.
If you have an account on dkNET then you can log in from here to get additional features in dkNET such as Collections, Saved Searches, and managing Resources.
Here is the search term that is being executed, you can type in anything you want to search for. Some tips to help searching:
If you are logged into dkNET you can add data records to your collections to create custom spreadsheets across multiple sources of data.
Here are the facets that you can filter the data by.
If you have any further questions please check out our FAQs Page to ask questions and see our tutorials. Click this button to view this tutorial again.
The NIDDK Information Network (dkNET) serves the needs of basic and clinical investigators by providing seamless access to large pools of data and research resources relevant to the mission of The National Institute of Diabetes Digestive and Kidney Diseases (NIDDK). dkNET is hosted at University of California San Diego, and is supported by NIH NIDDK grant U24DK097771.
Email: info_at_ dknet.org
